
==== Front
BMB RepBMB RepksbmbBMB Reports1976-66961976-670XKorean Society for Biochemistry and Molecular Biology 25388208BMB-47-65510.5483/BMBRep.2014.47.12.241Invited Mini ReviewIntegrin activation Ginsberg Mark H. *Department of Medicine, University of California, San Diego, La Jolla, California 92093, USA* Tel: 858-822-6432; Fax: 858-822-6458; E-mail: mhginsberg@ucsd.edu12 2014 47 12 655 659 07 11 2014 Copyright © 2014, Korean Society for Biochemistry and Molecular Biology2014This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Integrin-mediated cell adhesion is important for development, immune responses, hemostasis and wound healing. Integrins also function as signal transducing receptors that can control intracellular pathways that regulate cell survival, proliferation, and cell fate. Conversely, cells can modulate the affinity of integrins for their ligands a process operationally defined as integrin activation. Analysis of activation of integrins has now provided a detailed molecular understanding of this unique form of “inside-out” signal transduction and revealed new paradigms of how transmembrane domains (TMD) can transmit long range allosteric changes in transmembrane proteins. Here, we will review how talin and mediates integrin activation and how the integrin TMD can transmit these inside out signals. [BMB Reports 2014; 47(12): 655-659]

Cell adhesionIntegrinNanodiscSignal transductionTalinTransmembrane domain
==== Body
INTRODUCTION
Integrins, heterodimeric type I transmembrane proteins consisting of α and β subunits, are a major class of receptors involved in adhesive events that control development and lead to pathologies such as cancer and thrombosis. Eighteeen integrin α subunits and 8 β subunits heterodimerize to form 24 different integrins (1). Each subunit contains a single transmembrane domain (TMD) and a short cytoplasmic tail. Besides mediating cell adhesion, integrins transmit signals across the plasma membrane that regulate cell migration, cell survival and growth (2). Conversely, signals from inside cells can increase the binding of integrin extracellular domains to ligands, a process operationally defined as integrin activation. Integrin activation encompasses both changes in affinity of individual integrins due to conformational changes and avidity increases due to integrin clustering (3-5). Precise regulation of integrin activation is particularly important in controlling platelet aggregation through integrin αIIbβ3 (6). Rapid activation of this integrin at the site of a wound is required for hemostasis (7); conversely inappropriate activation of αIIbβ3 can cause a platelet thrombus to occlude a blood vessel resulting in myocardial infarction or stroke. Here we will discuss recent progress in understanding how integrins are activated.

INTEGRIN TMD-THE CONDUIT FOR ALLOSTERIC REARRANGEMENTS
Changes in the conformation of integrin extracellular domains are responsible for the changes in integrin monomer affinity. These conformational changes have been the subject of several excellent reviews (3, 8-12) and will not be discussed here. Similarly, clustering of integrins can enchance the binding of multivalent ligands and kindlins have recently emerged as major players in clustering (13). The capacity of intracellular signals to change the conformation of the extracellular domain requires a remarkable transmemebrane allosteric change, a change that must traverse the integrin TMD. Truncation of the integrins at the C-termini of extracellular domains results in constitutively active integrins (14), indicating that TMDs and cytoplasmic tails limit the activation state of integrins. Furthermore, many activating mutations, map to the α or β TMD (15-18). Heterodimeric interactions between α and β TMDs and cytoplasmic tails have been observed by co-immunoprecipitation (19), cysteine crosslinking (20, 21) and by NMR (22) in phospholipid bicelles, but not in detergent micelles (23). Importantly, mutations in TMDs that activate integrins invariably inhibit α and β TMD interactions (19). Thus, physiological integrin activation is likely to require that intracellular signals disrupt integrin αβ TMD interactions.

The structure of the αIIbβ3 TMD complex in a phospholipid bicelle (22) revealed the basis of association of the α and β through two interaction interfaces. The αIIb TMD helix is short, straight and broken at Gly991, the first residue of the highly-conserved Gly-Phe-Phe-Lys-Arg (GFFKR) motif in the membrane proximal region of the α subunits. The two Phe residues of the αIIb GFFKR motif do not form a continuous helix but instead make a sharp turn toward β3 (Fig. 1). In this way, the hydrophobic side chains of those residues reside in the hydrophobic core of the lipid bilayer and stack against hydrophobic residues in the β3 TMD, particularly Trp715 and Ile719. The turning of the membrane-proximal region of αIIb also permits the long-predicted (24) electrostatic interaction between αIIb Arg995 and β3 Asp723 by placing those residues in proximity (Fig. 1). The structure at the inner membrane interface is unique to and likely conserved in integrins and is termed the inner membrane clasp (IMC) (22). The second interface involves helical packing centered on β3 Gly708 and αIIb G972XXXG976 motif at the outer membrane region and is termed the outer membrane clasp (OMC) (Fig. 1). Integrin β3 TMD makes a long and continuous helix with a 25° tilting angle to enable the multipoint interactions with αIIb and accommodate the extra hydrophobic residues in the β3 TMD.

Fig. 1. Structure of integrin αIIbβ3 TMD (ribbon view; αIIb in red and β3 in blue. From PDB 2K9J) showing the two interaction interfaces. Right, outer membrane clasp (OMC) illustrating the helical packing involving αIIb Gly 702 and 706. Left, inner membrane clasp (IMC) showing the electrostatic interaction between αIIb Arg995 and β3 Asp723. Also depicted are the hydrophobic interactions of αIIb Phe992,933 with the β3 TMD. Adapted from reference (22).
As noted above, an important feature of the structure of the αIIbβ3 TMD dimer is that the helical β TMD must be precisely tilted to maintain simultaneous formation of the OMC and IMC. Precise tilt is maintained via β3 Lys716 whose alpha carbon resides in the hydrophobic region of the lipid bilayer but its positively charged ε-NH3+ is predicted to snorkel into the negatively charged phosphate head group region (25). Mutation of Lys716 any residue other than Arg (which also contains a snorkeling basic side chain) reduces α-β TMD interactions and dramatically increases integrin activation (25). The effects of Lys716 mutation can be ameliorated by breaking the continuous β TMD helix into two halves by introduction of a Pro mutation (A711P). The Pro mutation, introduces a flexible hinge that partially decouples the tilting angles of inner and outer helices favoring simultaneous formation of OMC and IMC (25).

TALIN “TILTS” THE INTEGRIN β TMD TO INDUCE ACTIVATION
Talin regulates integrin affinity and provides a mechanical link between integrins and the actin cytoskeleton. Talin comprises a 50-kDa N-terminal FERM domain (talin head domain or THD) that contains a high-affinity binding site for integrin β tails and a 220-kDa rod domain that contains multiple binding sites for actin and vinculin (26). The THD is further divided into F0, F1, F2 and F3 subdomains (26, 27). The F3 subdomain, contains the major integrin integrin β tail binding site (28, 29). The essential role of talin in regulating integrin affinity has been well documented in model cells (29-32), transgenic mice (33-36) and reconstituted systems with purified proteins (37). In in vitro systems, recombinant THD alone is sufficient to activate αIIbβ3 reconstituted in either liposomes or phospholipid nanodiscs, and activation is associated with a shift towards an αIIbβ3 extended conformation (37).

We now have considerable insight into how talin induces this allosteric rearrangement in integrins. Talin binds to two sites on integrin β tails: a strong binding site centered around the first NPxY motif that contributes most of the binding free energy and a weaker membrane proximal (MP) binding site (38). In addition, THD also binds to negatively charged phospholipids via positively-charged residues (38-40). The weak interaction with the MP region has two important effects: 1) it brings talin Lys324 close to Asp723 of the β3 tail, thus competing for the Arg995-Asp723 electrostatic interactions in IMC (40); 2) it stabilizes α-helical structure of the β MP region and to form a continuous helix with the β3 TMD (38, 40). As the simultaneous interaction with integrin β tails and phospholipids, can change the tilt angle of the β3 MP tail and thus of the contiguous β3 TMD (Fig. 2) (41). Such talin-induced motion was demonstrated by increased fluorescence of solvatochromic dyes attached to the N- or C-terminii of the β3 TMD in the presence of THD (41) and is further supported by molecular dynamic simulations (42). The change in tilting angle destabilizes α-β TMD interactions and shifts the equilibrium towards an activated integrin conformation. In further support of this model, introducing a flexible proline kink in the middle of the β3 TMD blocks THD-induced tilting of the outer membrane segment without blocking tilting of the inner membrane segment (Fig. 3). Integrins bearing this mutation are remarkably resistant to talin induced integrin activation (41).

Fig. 2. Talin changes the topology of the β3 TMD. A peptide containing the β3 TMD and cytoplasmic domain was labeled with environment sensitive bimanes at the outer edge of the TMD (N terminal labeling, Leu694) or at the TMD cytosol interface (C-terminal labeling, Ile721). The peptides were individually embedded in phospholipid nanodiscs and increasing concentrations of talin head domain (THD) were added and bimanes emission spectra were recorded. The increased fluorescence indicates that both sides of the β3 TMD were in a less polar environment suggesting that THD increased the tilting of the β3 TMD. Adapted from reference (41).
Fig. 3. A proline kink prevents transmission of altered tilt across the β3 TMD. In the left two panels The experimental design was identical to that in Fig. 2 and depicts the talin-induced increased embedding at both the inner (where THD binds) and outer edges of the TMD. Introduction of a flexible kink by β3 (A711P) mutation (right two panels) prevents the transmission of increased embedding of the inner TMD to the outer region. Adapted from reference (41).
SUMMARY AND CONCLUSIONS
Integrin activation was first observed in 1978 in integrin αIIbβ3 and it has proved to be a conserved property of β1, β2, and β3 integrins. As summarized here, our understanding of this unique form of transmembrane signal transduction has moved from a black box in which agonists, such as thrombin, caused a change in the affinity of integrin αIIbβ3. Today, cell biological and reverse genetic experiments have verified that talin binding to the integrin β cytoplasmic domain is a final common step in activation. Structural studies have revealed how two binding interfaces of talin with the integrin in combination with talin membrane binding sites can effect this form of transmembrane allostery. Studies have also revealed unique features of the heterodimeric integrin TMD that form a stable yet dynamic αβ TMD interaction that enables transmission of the activation signal across the phospholipid bilayer. The lessons learned in studying integrin transmembrane signaling, such as the importance of snorkeling basic residues in maintaining TMD topology, are likely to pertain to other examples of transmembrane signaling through transmembrane receptors.
==== Refs
1 Hynes R. O.   Integrins: bidirectional, allosteric signaling machines. Cell  (2002) 110 673 687 10.1016/S0092-8674(02)00971-6 12297042 
2 Giancotti F. G.  Ruoslahti E.   Integrin signaling. Science  (1999) 285 1028 1032 10.1126/science.285.5430.1028 10446041 
3 Kim C.  Ye F.  Ginsberg M. H.   Regulation of integrin activation. Annu. Rev. Cell. Dev. Biol.  (2011) 27 321 345 10.1146/annurev-cellbio-100109-104104 21663444 
4 Shattil S. J.  Kim C.  Ginsberg M. H.   The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell. Biol.  (2010) 11 288 300 10.1038/nrm2871 20308986 
5 Shattil S. J.  Newman P. J.   Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood  (2004) 104 1606 1615 10.1182/blood-2004-04-1257 15205259 
6 Wagner C. L.  Mascelli M. A.  Neblock D. S.  Weisman H. F.  Coller B. S.  Jordan R. E.   Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood  (1996) 88 907 914 8704248 
7 Shattil S. J.  Kashiwagi H.  Pampori N.   Integrin signaling: the platelet paradigm. Blood  (1998) 91 2645 2657 9531572 
8 Luo B. H.  Carman C. V.  Springer T. A.   Structural basis of integrin regulation and signaling. Annu. Rev. Immunol.  (2007) 25 619 647 10.1146/annurev.immunol.25.022106.141618 17201681 
9 Arnaout M. A.  Goodman S. L.  Xiong J. P.   Structure and mechanics of integrin-based cell adhesion. Curr. Opin. Cell. Biol.  (2007) 19 495 507 10.1016/j.ceb.2007.08.002 17928215 
10 Luo B. H.  Springer T. A.   Integrin structures and conformational signaling. Curr. Opin. Cell. Biol.  (2006) 18 579 586 10.1016/j.ceb.2006.08.005 16904883 
11 Arnaout M. A.  Mahalingam B.  Xiong J. P.   Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell. Dev. Biol.  (2005) 21 381 410 10.1146/annurev.cellbio.21.090704.151217 16212500 
12 Shimaoka M.  Takagi J.  Springer T. A.   Conformational regulation of integrin structure and function. Annu. Rev. Biophys. Biomol. Struct.  (2002) 31 485 516 10.1146/annurev.biophys.31.101101.140922 11988479 
13 Ye F.  Petrich B. G.  Anekal P.  Lefort C. T.  Kasirer-Friede A.  Shattil S. J.  Ruppert R.  Moser M.  Fässler R.  Ginsberg M. H.   The Mechanism of Kindlin-mediated Activation of Integrin αIIbβ3. Curr. Biol.  (2013) 23 2288 2295 10.1016/j.cub.2013.09.050 24210614 
14 Mehta R. J.  Diefenbach B.  Brown A.  Cullen E.  Jonczyk A.  Güssow D.  Luckenbach G. A.  Goodman S. L.   Transmembrane-truncated alphavbeta3 integrin retains high affinity for ligand binding: evidence for an 'inside-out' suppressor? Biochem. J.  (1998) 330 861 869 9480902 
15 Partridge A. W.  Liu S.  Kim S.  Bowie J. U.  Ginsberg M. H.   Transmembrane domain helix packing stabilizes integrin alphaIIbbeta3 in the low affinity state. J. Biol. Chem.  (2005) 280 7294 7300 10.1074/jbc.M412701200 15591321 
16 Luo B. H.  Carman C. V.  Takagi J.  Springer T. A.   Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering. Proc. Natl. Acad. Sci. U. S. A.  (2005) 102 3679 3684 10.1073/pnas.0409440102 15738420 
17 Li W.  Metcalf D. G.  Gorelik R.  Li R.  Mitra N.  Nanda V.  Law P. B.  Lear J. D.  Degrado W. F.  Bennett J. S.   A push-pull mechanism for regulating integrin function. Proc. Natl. Acad. Sci. U. S. A.  (2005) 102 1424 1429 10.1073/pnas.0409334102 15671157 
18 Li R.  Mitra N.  Gratkowski H.  Vilaire G.  Litvinov R.  Nagasami C.  Weisel J. W.  Lear J. D.  DeGrado W. F.  Bennett J. S.   Activation of integrin alphaIIbbeta3 by modulation of transmembrane helix associations. Science  (2003) 300 795 798 10.1126/science.1079441 12730600 
19 Kim C.  Lau T. L.  Ulmer T. S.  Ginsberg M. H.   Interactions of platelet integrin alphaIIb and beta3 transmembrane domains in mammalian cell membranes and their role in integrin activation. Blood  (2009) 113 4747 4753 10.1182/blood-2008-10-186551 19218549 
20 Zhu J.  Luo B. H.  Barth P.  Schonbrun J.  Baker D.  Springer T. A.   The structure of a receptor with two associating transmembrane domains on the cell surface: integrin alphaIIbbeta3. Mol. Cell  (2009) 34 234 249 10.1016/j.molcel.2009.02.022 19394300 
21 Luo B. H.  Springer T. A.  Takagi J.   A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol.  (2004) 2 e153 10.1371/journal.pbio.0020153 15208712 
22 Lau T. L.  Kim C.  Ginsberg M. H.  Ulmer T. S.   The structure of the integrin alphaIIbbeta3 transmembrane complex explains integrin transmembrane signalling. EMBO J.  (2009) 28 1351 1361 10.1038/emboj.2009.63 19279667 
23 Li R.  Babu C. R.  Lear J. D.  Wand A. J.  Bennett J. S.  DeGrado W. F.   Oligomerization of the integrin alphaIIbbeta3: roles of the transmembrane and cytoplasmic domains. Proc. Natl. Acad. Sci. U. S. A.  (2001) 98 12462 12467 10.1073/pnas.221463098 11606749 
24 Hughes P. E.  Diaz-Gonzalez F.  Leong L.  Wu C.  McDonald J. A.  Shattil S. J.  Ginsberg M. H.   Breaking the integrin hinge: a defined structural constraint regulates integrin signaling. J. Biol. Chem.  (1996) 271 6571 6574 10.1074/jbc.271.12.6571 8636068 
25 Kim C.  Schmidt T.  Cho E. G.  Ye F.  Ulmer T. S.  Ginsberg M. H.   Basic amino-acid side chains regulate transmembrane integrin signalling. Nature  (2012) 481 209 213 10.1038/nature10697 
26 Critchley D. R.   Biochemical and structural properties of the integrin-associated cytoskeletal protein talin. Annu. Rev. Biophys  (2009) 38 235 254 10.1146/annurev.biophys.050708.133744 19416068 
27 Elliott P. R.  Goult B. T.  Kopp P. M.  Bate N.  Grossmann J. G.  Roberts G. C.  Critchley D. R.  Barsukov I. L.   The Structure of the talin head reveals a novel extended conformation of the FERM domain. Structure  (2010) 18 1289 1299 10.1016/j.str.2010.07.011 20947018 
28 Calderwood D. A.  Fujioka Y.  de Pereda J. M.  García-Alvarez B.  Nakamoto T.  Margolis B.  McGlade C. J.  Liddington R. C.  Ginsberg M. H.   Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc. Natl. Acad. Sci. U. S. A.  (2003) 100 2272 2277 10.1073/pnas.262791999 12606711 
29 Calderwood D. A.  Yan B.  de Pereda J. M.  Alvarez B. G.  Fujioka Y.  Liddington R. C.  Ginsberg M. H.   The phosphotyrosine binding-like domain of talin activates integrins. J. Biol. Chem.  (2002) 277 21749 21758 10.1074/jbc.M111996200 11932255 
30 Lee H. S.  Lim C. J.  Puzon-McLaughlin W.  Shattil S. J.  Ginsberg M. H.   RIAM activates integrins by linking talin to ras GTPase membrane-targeting sequences. J. Biol. Chem.  (2009) 284 5119 5127 10.1074/jbc.M807117200 19098287 
31 Han J.  Lim C. J.  Watanabe N.  Soriani A.  Ratnikov B.  Calderwood D. A.  Puzon-McLaughlin W.  Lafuente E. M.  Boussiotis V. A.  Shattil S. J.  Ginsberg M. H.   Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr. Biol.  (2006) 16 1796 1806 10.1016/j.cub.2006.08.035 16979556 
32 Calderwood D. A.  Zent R.  Grant R.  Rees D. J.  Hynes R. O.  Ginsberg M. H.   The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J. Biol. Chem.  (1999) 274 28071 28074 10.1074/jbc.274.40.28071 10497155 
33 Petrich B. G.  Marchese P.  Ruggeri Z. M.  Spiess S.  Weichert R. A.  Ye F.  Tiedt R.  Skoda R. C.  Monkley S. J.  Critchley D. R.  Ginsberg M. H.   Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J. Exp. Med.  (2007) 204 3103 3111 10.1084/jem.20071800 18086863 
34 Nieswandt B.  Moser M.  Pleines I.  Varga-Szabo D.  Monkley S.  Critchley D.  Fässler R.   Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo. J. Exp. Med.  (2007) 204 3113 3118 10.1084/jem.20071827 18086864 
35 Petrich B. G.  Fogelstrand P.  Partridge A. W.  Yousefi N.  Ablooglu A. J.  Shattil S. J.  Ginsberg M. H.   The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation. J. Clin. Invest.  (2007) 117 2250 2259 10.1172/JCI31024 17627302 
36 Haling J. R.  Monkley S. J.  Critchley D. R.  Petrich B. G.   Talin-dependent integrin activation is required for fibrin clot retraction by platelets. Blood  (2011) 117 1719 1722 10.1182/blood-2010-09-305433 20971947 
37 Ye F.  Hu G.  Taylor D.  Ratnikov B.  Bobkov A. A.  McLean M. A.  Sligar S. G.  Taylor K. A.  Ginsberg M. H.   Recreation of the terminal events in physiological integrin activation. J. Cell. Biol.  (2010) 188 157 173 10.1083/jcb.200908045 20048261 
38 Wegener K. L.  Partridge A. W.  Han J.  Pickford A. R.  Liddington R. C.  Ginsberg M. H.  Campbell I. D.   Structural basis of integrin activation by talin. Cell  (2007) 128 171 182 10.1016/j.cell.2006.10.048 17218263 
39 Goult B. T.  Bouaouina M.  Elliott P. R.  Bate N.  Patel B.  Gingras A. R.  Grossmann J. G.  Roberts G. C.  Calderwood D. A.  Critchley D. R.  Barsukov I. L.   Structure of a double ubiquitin-like domain in the talin head: a role in integrin activation. EMBO J.  (2010) 29 1069 1080 10.1038/emboj.2010.4 20150896 
40 Anthis N. J.  Wegener K. L.  Ye F.  Kim C.  Goult B. T.  Lowe E. D.  Vakonakis I.  Bate N.  Critchley D. R.  Ginsberg M. H.  Campbell I. D.   The structure of an integrin/talin complex reveals the basis of inside-out signal transduction. EMBO J.  (2009) 28 3623 3632 10.1038/emboj.2009.287 19798053 
41 Kim C.  Ye F.  Hu X.  Ginsberg M. H.   Talin activates integrins by altering the topology of the beta transmembrane domain. J. Cell. Biol.  (2012) 197 605 611 10.1083/jcb.201112141 22641344 
42 Kalli A. C.  Wegener K. L.  Goult B. T.  Anthis N. J.  Campbell I. D.  Sansom M. S.   The structure of the talin/integrin complex at a lipid bilayer: an NMR and MD simulation study. Structure  (2010) 18 1280 1288 10.1016/j.str.2010.07.012 20947017
